FibroGen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO

Thane Wettig

CEOThane Wettig

Employees

225

Employees225

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1993

Founded1993

Employees

225

Employees225

FGEN Key Statistics

Market cap

31.28M

Market cap31.28M

Price-Earnings ratio

-3.18

Price-Earnings ratio-3.18

Dividend yield

—

Dividend yield—

Average volume

60.69K

Average volume60.69K

High today

$8.36

High today$8.36

Low today

$7.65

Low today$7.65

Open price

$8.16

Open price$8.16

Volume

15.06K

Volume15.06K

52 Week high

$38.25

52 Week high$38.25

52 Week low

$4.50

52 Week low$4.50

FGEN News

TipRanks 4d

FibroGen Amends Financing Agreement with Morgan Stanley

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.